// App-Quantinova.ai

9561 : Treatment outcomes in patients (pts) with melanoma brain metastases (MBM) treated with systemic therapy: A systematic literature review (SLR) and meta-analysis.

Researchers

Presenter

  • Hussein Abdul-Hassan Tawbi

Principal Investigators

  • Georgina V. Long

  • Nicolas Meyer

  • Boris Breznen

  • Charmy Vyas

  • Lisa Leung

  • Andriy Moshyk

  • Divya Pushkarna

  • Pratik K. Thakkar

  • Mir Sohail Fazeli

  • SRIVIDYA KOTAPATI

  • Dirk Schadendorf

Medical Centers

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

  • Melanoma Institute Australia, The...

  • University of Sydney and Royal North Shore and Mater Hospitals, Sydney, Australia

  • Institut Universitaire du Cancer de Toulouse and Centre Hospitalier Universitaire (CHU), Toulouse, France

  • Evidinno Outcomes Research Inc., Vancouver, BC, Canada

  • Bristol Myers Squibb, Princeton, NJ, Bristol Myers Squibb, Uxbridge, United Kingdom

  • Department of Dermatology, University of Essen; German Cancer Consortium (DKTK), Partner Site Essen, Essen, Germany

Locations

  • Australia

  • France

  • Canada

  • United Kingdom

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Brain metastasis

  • Melanoma

Biomarkers

  • N/A

Drug/Treatment

  • Ipilimumab

  • Nivolumab

Outcome

  • N/A

Study Design

  • Controlled

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved